Patent details

Basic Information

Publication number:

EP3856767

PCT Application Number:

EP2019076304

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197798663

PCT Publication Number:

WO2020065063

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

French Title of Invention:

FORMULATIONS D'ANALOGUES GLUCAGON-LIKE-PEPTIDE-2 (GLP-2)

German Title of Invention:

FORMULIERUNGEN VON ANALOGA DES GLUCAGON-LIKE-PEPTID-2 (GLP-2)

SPC Number:

Dates

Filing date:

27/09/2019

Grant date:

27/03/2024

EP Publication Date:

04/08/2021

PCT Publication Date:

02/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/03/2024

EP B1 Publication Date:

27/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/09/2024

Expiration date:

27/09/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/03/2024

 

 

Name:

Zealand Pharma A/S

Address:

Sydmarken 11, 2860 Søborg, Denmark (DK)

Inventor

1

Name:

GIEHM, Lise

Address:

Denmark (DK)

2

Name:

PARSHAD, Henrik Rajesh Kumar

Address:

Denmark (DK)

3

Name:

MELANDER, Claes

Address:

Denmark (DK)

Priority

Priority Number:

18197750

Priority Date:

28/09/2018

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 14/605; A61K 38/26; A61K 38/00;

Publication

European Patent Bulletin

Issue number:

202413

Publication date:

27/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages